Metabolic Disease Services Platform
Metabolic diseases are considered to arise from multiple factors, including genetics, diet, age, and environmental factors, and often affect various organs throughout the body. No single cause is solely responsible for these disorders.
To support research in this area, WuXi AppTec offers a comprehensive platform of in vitro and in vivo services. Our capabilities include a well-established panel of validated and clinically relevant animal models, as well as advanced technologies for studying obesity, diabetes, hyperlipidemia, and rare metabolic diseases.
• Clinically relevant models that mirror clinical profiles for effective drug screening and assessment.
• Comprehensive system for metabolic disease treatment evaluation.
• Extensive metabolic research experience and robust drug evaluation system.
Learn more about our metabolic disease service platform by clicking HERE

Metabolic Disease Platform
Related Content
Multi-target drugs targeting GLP1R/GIPR/GCGR have demonstrated superior efficacy for weight loss and glycemic control compared to single-target GLP1R drugs. However,...
VIEW RESOURCEIntegrating drug targets, molecular types, and clinical translation Introduction: Metabolic dysfunction-associated steatohepatitis (MASH), a growing global health concern, has garnered...
VIEW RESOURCE
